EpiWatch - Seizure Monitor
60
Quality Score
Solid
EpiWatch - Seizure Monitor
by EpiWatch, Inc.
Low confidence
✍️ bumetric analysis
“
EpiWatch - Seizure Monitor is an iOS app from EpiWatch, Inc. in the Education category, currently rated 4.1★ across 50 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 60: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$200
per month
→
12-mo forecast
$100 – $931
per month
→
24-mo forecast
$100 – $2790
per month
MICRO tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$80K
↳ What it cost to build · not monthly revenue
Likely range $60K – $110K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~5 months at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (91 MB) | +$16K |
| ⚙ Education complexity ×1.20 | +$13K |
Total estimate
$80K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$225K
↳ What it would sell for · not monthly revenue
Marketplace range $175K – $300K · 15× MRR multiple
💸
~2.8× return on build cost
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
15× MRR
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$200/mo · ML-estimated from 234 triggers
Growth rate
+8.0% MoM · MICRO tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition, low defensibility moat
6 months
$127 – $508
12 months
$100 – $931
24 months
$100 – $2.8K
Compound growth at +8.0% MoM (tier baseline for MICRO). Range widens with horizon — typical noise band ±60% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Insufficient data · 37/100MICRO TIERtoo early to scoreRevenue Strength
2.3
Product Quality
3.3
Market Position
0.3
Growth Velocity
5.0
Defensibility
2.2
Operational Safety
10.0
Founder Strength
5.2
Monetization Maturity
1.0
- 💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
- ⭐ Quality: 4.12★ across 50 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $3K-$6K. Portfolio play ($15K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 6 of 6 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| subscriptionREVIEW | +$2,500 | |
| Good rating (4.1★)METRIC | +$800 | |
| New app (10 months old)METRIC | −$700 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (50 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v1.2.7
What's New:
- Added a Contact Support option in Settings to submit support requests directly from the app.
Bug Fixes & Improvements:
- General reliability improvements.
- Added a Contact Support option in Settings to submit support requests directly from the app.
Bug Fixes & Improvements:
- General reliability improvements.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- EpiWatch - Seizure Monitor
- Developer
- EpiWatch, Inc.
- Bundle ID
- com.epiwatch.public
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 4+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $15.3K/mo
- Top-grossing rank
- 🇺🇸#55 /100
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth50 ratings+355% lifetimeShow 3-year history estimate ▾
Tracked (19 weeks) Pre-tracking estimate (11 weeks) · model-based, ±5% noise · anchored to release date and current value
🗺️Geographic Distribution1 of 9 markets
🇺🇸
US
Top-grossing rank: #55 / 100
Other markets
Outside top 100
in US, GB, DE, FR, JP, CA, AU, BR, IN
in US, GB, DE, FR, JP, CA, AU, BR, IN
This app currently ranks in only one of the 9 markets we monitor. Niche or regional apps often launch this way before global rollout. Rankings update daily.
📊Category Rank Trajectory#55 now · best #41 · worst #100
Lower line = better rank · Estimate from ratings growth model · Lower position on chart = worse rank · Higher = top of chart
🚀Update Frequency · Releases per Quarter3 releases tracked
🚀Version Release Timeline3 releases tracked
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
EpiWatch: Seizure Monitoring and Alerting
FDA-cleared Seizure Detection
SAFETY, INDEPENDENCE, AND PEACE OF MIND
Take control of seizure safety with EpiWatch, the only clinically validated and FDA-cleared tonic-clonic seizure detection
and alerting app for Apple Watch. EpiWatch is available in the U.S. Seizure detection, monitoring, and caregiver alerting require a prescription from a U.S. clinician.
CLINICALLY VALIDATED SEIZURE DETECTION
EpiWatch is powered by an FDA-cleared seizure detection algorithm that detected 98% of tonic-clonic seizures in clinical… View full description on the official store →
FDA-cleared Seizure Detection
SAFETY, INDEPENDENCE, AND PEACE OF MIND
Take control of seizure safety with EpiWatch, the only clinically validated and FDA-cleared tonic-clonic seizure detection
and alerting app for Apple Watch. EpiWatch is available in the U.S. Seizure detection, monitoring, and caregiver alerting require a prescription from a U.S. clinician.
CLINICALLY VALIDATED SEIZURE DETECTION
EpiWatch is powered by an FDA-cleared seizure detection algorithm that detected 98% of tonic-clonic seizures in clinical… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 91 MB🔞 4+📱 iOS 17.0+🔖 v1.2.7🔄 updated 0d ago🌐 EN📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
8 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-07
🔧
Shipped update — v1.2.6 → v1.2.7
→ 30 days after: rating +0.11★ · reviews +14 high confidence
2026-06
🔧
Shipped update — v1.2.5 → v1.2.6
→ 30 days after: revenue +$14.3K/mo · rating +0.11★ · reviews +29 high confidence
2026-06
📈
Crossed 10 ratings — social-proof flywheel kicking in
→ 30 days after: rating +0.12★ · reviews +18 high confidence
2026-06
⭐
Rating ↑ 3.33 → 4.12 (improved 0.79★)
→ 30 days after: rating +0.12★ · reviews +18 high confidence
2026-03
⭐
Rating ↓ 4.17 → 3.33 (dropped 0.84★)
→ 30 days after: revenue −$1.1K/mo · rating −0.84★ high confidence
2026-03
⭐
Rating ↓ 4.50 → 4.17 (dropped 0.33★)
→ 30 days after: revenue −$1.1K/mo · rating −0.84★ high confidence
2026-02
⭐
Rating ↓ 5.00 → 4.50 (dropped 0.50★)
→ 30 days after: revenue +$1.4K/mo · rating −0.33★ high confidence
2025-12
🚀
First tracked snapshot — initial data captured
→ 30 days after: revenue +$344/mo · rating −0.50★ high confidence
🧪
Tech & Domain Intel — epiwatch.com
- Mail provider
- Google Workspace
- Tech stack
- Google Workspace
Derived from public RDAP + DNS TXT records (no scraping, no login).
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
About this analysis
Why low confidence: only 50 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does EpiWatch - Seizure Monitor make per month?▴
Based on our ML-calibrated revenue forecast, EpiWatch - Seizure Monitor earns approximately $15K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like EpiWatch - Seizure Monitor?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes EpiWatch - Seizure Monitor?▴
EpiWatch - Seizure Monitor is published by EpiWatch, Inc. on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is EpiWatch - Seizure Monitor's BU Score?▴
EpiWatch - Seizure Monitor has a BU Score of 60/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.